Detalles de la búsqueda
1.
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 194: 106859, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37473877
2.
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.
Int J Mol Sci
; 24(2)2023 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675312
3.
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 196: 106938, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748560
4.
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Biomed Pharmacother
; 173: 116299, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38401525
5.
Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain.
Pharmaceutics
; 14(10)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36297516
Resultados
1 -
5
de 5
1
Próxima >
>>